Clinical trial
A Priming Intervention to Increase Patient Willingness to Use Injectables for the Management of Psoriasis
NCT03465696 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Priming Intervention to Increase Patient Willingness to Use Injectables for the Management of Psoriasis
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 14, 2018
- Completion date
- June 21, 2019
- Enrollment
- 180 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.